Arteris, Inc. (NASDAQ:AIP – Get Free Report) COO Laurent Moll sold 5,600 shares of the business’s stock in a transaction that occurred on Friday, October 2nd. The stock was sold at an average price of $24.64, for a total value of $137,984.00. Following the transaction, the chief operating officer owned 206,878 shares in the company, valued at approximately $5,097,473.92. This represents a 2.64% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. The sale was made to cover tax withholding obligations related to the vesting of equity awards.
Arteris Stock Down 2.4%
Shares of AIP opened at $22.84 on Friday. Arteris, Inc. has a 52-week low of $12.06 and a 52-week high of $50.26. The company has a market capitalization of $1.12 billion, a PE ratio of -26.25 and a beta of 1.90. The stock has a fifty day simple moving average of $24.44 and a two-hundred day simple moving average of $28.78. The company has a quick ratio of 1.57, a current ratio of 1.57 and a debt-to-equity ratio of 0.03.
Arteris (NASDAQ:AIP – Get Free Report) last released its quarterly earnings results on Thursday, August 6th. The company reported ($0.10) EPS for the quarter, missing the consensus estimate of ($0.04) by ($0.06). Arteris had a negative net margin of 46.70% and a negative return on equity of 295.96%. The firm had revenue of $24.13 million for the quarter, compared to analysts’ expectations of $23.48 million. As a group, equities analysts forecast that Arteris, Inc. will post -0.68 EPS for the current year.
Analyst Ratings Changes
Check Out Our Latest Analysis on Arteris
Hedge Funds Weigh In On Arteris
Several hedge funds have recently made changes to their positions in the company. Needham Investment Management LLC increased its position in shares of Arteris by 2.6% during the fourth quarter. Needham Investment Management LLC now owns 3,411,500 shares of the company’s stock worth $52,878,000 after purchasing an additional 86,500 shares in the last quarter. BlackRock Inc. acquired a new stake in shares of Arteris in the 2nd quarter valued at about $160,129,000. Granahan Investment Management LLC grew its stake in Arteris by 201.0% during the 1st quarter. Granahan Investment Management LLC now owns 713,077 shares of the company’s stock worth $11,723,000 after buying an additional 476,181 shares during the last quarter. Wellington Management Group LLP grew its stake in Arteris by 0.4% during the 2nd quarter. Wellington Management Group LLP now owns 500,200 shares of the company’s stock worth $24,305,000 after buying an additional 1,897 shares during the last quarter. Finally, Algert Global LLC purchased a new position in Arteris during the 2nd quarter worth approximately $11,602,000. Hedge funds and other institutional investors own 64.36% of the company’s stock.
Trending Headlines about Arteris
Here are the key news stories impacting Arteris this week:
- Positive Sentiment: Arteris received an additional $3.3 million from the Trusted and Assured Microelectronics program to expand its third-party semiconductor IP security-assurance initiative with BAE Systems and SiFive. The funding supports Arteris’ role in securing hardware-design supply chains and may improve its positioning in government and advanced-chip projects. Arteris funding article
- Positive Sentiment: The funding has renewed the “undervalued” investment narrative around Arteris, with investors focusing on potential long-term demand for semiconductor security and the company’s strategic partnerships. Oppenheimer also maintained its Buy rating, reinforcing the constructive analyst view. Arteris undervalued narrative article Oppenheimer rating article
- Neutral Sentiment: CEO K. Charles Janac, COO Laurent Moll and VP Paul Alpern reported multiple share sales. Several transactions were associated with tax-withholding obligations when equity awards vested, which limits their value as a signal of weakening management confidence. Laurent Moll insider sale
- Negative Sentiment: Bayview Legacy LLC sold 100,000 shares, worth approximately $2.38 million. Unlike the executive transactions, the filing did not identify tax withholding as the reason, potentially adding selling pressure and investor caution, although the holder still retains a sizable position. Bayview Legacy insider sale
- Negative Sentiment: Arteris’ latest quarterly EPS loss was wider than analysts expected, and the company remains unprofitable. That fundamental backdrop may be offsetting optimism about the new funding and analyst support.
Arteris Company Profile
Arteris, Inc is a semiconductor intellectual property (IP) company that develops technologies used in the design of system-on-chip (SoC) devices. Its products help semiconductor and electronics companies connect, manage and protect the various processing, memory and other functional components integrated into complex chips.
The company’s portfolio includes network-on-chip (NoC) interconnect IP, which supports communication among different elements within an SoC, as well as cache-coherent interconnect, system IP and related design technologies.
See Also
- Five stocks we like better than Arteris
- Want Private-Market Access to Kalshi and Polymarket? Try This ETF
- Levi’s Stock Dip Reveals Value Opportunity Despite Q3 Headwinds
- PepsiCo Stock Looks Poised to Bottom With High Yield, Deep Value
- Alphabet’s $1.8 Billion Black Hills Deal Powers AI Data Center Push
Receive News & Ratings for Arteris Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Arteris and related companies with MarketBeat.com's FREE daily email newsletter.
